APR. Yasmine Michielsen SRL
APR. Yasmine Michielsen reported total assets of 41,956 € at the end of the 2025 financial year (annual accounts filed with the NBB on 06 Aug 2026).
The score of APR. Yasmine Michielsen shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +183 % Total assets -4 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
APR. Yasmine Michielsen's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 06 Aug 2026
- Year ended 31 Dec 2024filed on 16 Jul 2025
- Year ended 31 Dec 2023filed on 14 Aug 2024
- Year ended 31 Dec 2022filed on 22 Jul 2023
- Year ended 31 Dec 2021filed on 25 Jul 2022
APR. Yasmine Michielsen's financial analysis
- Solvency45.1%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of APR. Yasmine Michielsen
APR. Yasmine Michielsen's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0524.757.924
- VAT number
- BE0524757924
- Peppol
- Registered · 0208:0524757924 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 22 Mar 2013
- Registered office
- 2960 Brecht
- Latest accounts
- 2025 · filed on 06 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
APR. Yasmine Michielsen (SRL) has been based in Brecht since 2013, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 3,474 € and equity of 18,928 €; its revenue is not published. Its solvency stands at 45.1%, above the median of its sector (44.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to APR. Yasmine Michielsen
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie Pharmiste Retail sale of pharmaceutical products Brussels · balance sheet 57,475 €
- ConSaJo Retail sale of pharmaceutical products Stabroek · balance sheet 42,199 €
- LP Society Retail sale of pharmaceutical products Fontaine-l'Évêque · balance sheet 41,178 €
- Adkg Retail sale of pharmaceutical products Brussels · balance sheet 43,380 €
- VanbaelenApo Retail sale of pharmaceutical products Bruges · balance sheet 39,958 €
- P.Stievanin Partner Solutions Retail sale of pharmaceutical products Binche · balance sheet 39,868 €
- Apotheek Sint-Anna Retail sale of pharmaceutical products Koekelberg · balance sheet 141,322 €
- WE Farma Retail sale of pharmaceutical products Oosterzele · balance sheet 39,748 €
Frequently asked questions about APR. Yasmine Michielsen
What is the revenue of APR. Yasmine Michielsen?
APR. Yasmine Michielsen files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of APR. Yasmine Michielsen?
In Belgium, the VAT number is the company number prefixed with BE: BE0524757924 for APR. Yasmine Michielsen, if the company is VAT-registered. Its company number (CBE) is 0524.757.924.
Where is the registered office of APR. Yasmine Michielsen?
According to the CBE register, the registered office of APR. Yasmine Michielsen is in 2960 Brecht.
What is the equity of APR. Yasmine Michielsen?
At the close of the 2025 financial year, the equity of APR. Yasmine Michielsen amounts to 18,928 €, a solvency of 45.1% of total assets.
Who manages APR. Yasmine Michielsen?
The register lists 1 active mandates at APR. Yasmine Michielsen. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of APR. Yasmine Michielsen
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →